Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT06754462

Public ClinicalTrials.gov record NCT06754462. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multicenter, Double-blind, Placebo-controlled Randomized Withdrawal Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat, ACPA-Positive Rheumatoid Arthritis

Study identification

NCT ID
NCT06754462
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Immunovant Sciences GmbH
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

  • IMVT-1402 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 9, 2025
Primary completion
Aug 31, 2027
Completion
Aug 31, 2027
Last update posted
Apr 21, 2026

2025 – 2027

United States locations

U.S. sites
34
U.S. states
15
U.S. cities
33
Facility City State ZIP Site status
Site Number - 1018 Mesa Arizona 85210
Site Number - 1019 Sun City Arizona 85351
Site Number - 1022 Covina California 91722
Site Number - 1028 San Leandro California 94578
Site Number - 1024 Temecula California 92592
Site Number - 1033 Tujunga California 91042
Site Number - 1023 Whittier California 90602
Site Number - 1020 Denver Colorado 80230
Site Number - 1015 Jupiter Florida 33458
Site Number - 1002 Miami Florida 33143
Site Number - 1027 Plantation Florida 33324
Site Number - 1005 Winter Park Florida 32789
Site Number - 1012 Zephyrhills Florida 33542
Site Number - 1001 Gainesville Georgia 30501
Site Number - 1034 Chicago Illinois 60607
Site Number - 1006 Cumberland Maryland 21502
Site Number - 1007 Hagerstown Maryland 21740
Site Number - 1031 Rockville Maryland 20850
Site Number - 1008 Worcester Massachusetts 01605
Site Number - 1021 Saint Clair Shores Michigan 48081
Site Number - 1030 Kansas City Missouri 64151
Site Number - 1010 Summit New Jersey 07901
Site Number - 1004 Charlotte North Carolina 28207
Site Number - 1035 Statesville North Carolina 28625
Site Number - 1000 Duncansville Pennsylvania 16635
Site Number - 1016 Jackson Tennessee 38305
Site Number - 1026 Memphis Tennessee 38119
Site Number - 1029 Murfreesboro Tennessee 37128
Site Number - 1037 Allen Texas 75013
Site Number - 1017 Colleyville Texas 76034
Site Number - 1036 Katy Texas 77494
Site Number - 1014 Mesquite Texas 75150
Site Number - 1013 Tomball Texas 77375
Site Number - 1025 Tomball Texas 77377

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06754462, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06754462 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →